Nov 5, 2022

Dr Brian Kennedy — validating aging interventions and why rapamycin is the gold standard

Posted by in categories: business, education, life extension

Dr Brian Kennedy explains why verifying longevity interventions work is key and why the transition to human trials is so important.

Brian Kennedy is one of the busiest people in the longevity business, with fingers in many of the most interesting antiaging pies. He was at the Longevity Investors Conference recently, discussing some of the latest discoveries in longevity research and giving a longevity industry overview.

The Longevity Investors Conference (LIC) is the world’s leading and most private longevity-focused investors-only conference. Providing relevant insights into the fast-growing field of longevity, the conference also offers expert education and investment opportunities, as well as fostering excellent networking opportunities. It was our privilege to attend and talk to so many key opinion leaders.

Visit Longevity. Technology —

Follow Longevity. Technology on:
Twitter —
Facebook —
Instagram —
Linkedin —

Comments are closed.